Literature DB >> 9194168

Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer.

A A Kortt1, M Lah, G W Oddie, C L Gruen, J E Burns, L A Pearce, J L Atwell, A J McCoy, G J Howlett, D W Metzger, R G Webster, P J Hudson.   

Abstract

Single-chain variable fragments (scFvs) of anti-neuraminidase antibody NC10 were constructed by joining the VH and VL domains with 10-residue (Gly4Ser)2 and five-residue (Gly4Ser) linkers; a zero-residue linker scFv was constructed by joining the C-terminal residue of the VH domain to the N-terminus of the VL domain. The scFv with the 10- and five-residue linkers exclusively formed dimeric antibody fragments (M(r) 52000). These were shown to be bivalent and were able to cross-link two neuraminidase tetramers to form a 'sandwich' type complex; each antigen combining site could also bind an anti-idiotype Fab'. The zero-residue linker scFv (M(r) 70000) was shown to form a trimer with three active antigen combining sites, each binding an anti-idiotype Fab' to yield a complex of M(r) 212000. The orientation of the combining sites in the zero-residue linker scFv, however, was such that it could not cross-link tetramers of neuraminidase. BIAcore biosensor experiments showed that the affinity of each individual antigen combining site in both the 10- and five-residue linker scFv dimers and zero-residue linker scFv trimer was essentially the same when the scFvs were immobilized onto the sensor surface. However, when the scFvs were used as the analyte, the dimeric and trimeric scFvs showed an apparent increase in binding affinity due to the avidity of binding the multivalent scFvs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194168     DOI: 10.1093/protein/10.4.423

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  20 in total

Review 1.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

2.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

3.  Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin B.

Authors:  Pawan Kumar Singh; Ranu Agrawal; Dev Vrat Kamboj; Garima Gupta; M Boopathi; Ajay Kumar Goel; Lokendra Singh
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

4.  Strength of multiple parallel biological bonds.

Authors:  Todd Sulchek; Raymond W Friddle; Aleksandr Noy
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

5.  Homology modelling and bivalent single-chain Fv construction of anti-HepG2 single-chain immunoglobulin Fv fragments from a phage display library.

Authors:  Ming Ni; Bing Yu; Yu Huang; Zhenjie Tang; Ping Lei; Xin Shen; Wei Xin; Huifen Zhu; Guanxin Shen
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

6.  Oligovalent Fab display on M13 phage improved by directed evolution.

Authors:  Tuomas Huovinen; Hanna Sanmark; Jani Ylä-Pelto; Markus Vehniäinen; Urpo Lamminmäki
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

7.  Optimization of the crystallizability of a single-chain antibody fragment.

Authors:  Jana Škerlová; Vlastimil Král; Milan Fábry; Juraj Sedláček; Václav Veverka; Pavlína Rezáčová
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

8.  Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

Authors:  H J de Haard; B Kazemier; M J Koolen; L J Nijholt; R H Meloen; B van Gemen; H R Hoogenboom; J W Arends
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

10.  Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation.

Authors:  Richard Tavaré; Wei H Wu; Kirstin A Zettlitz; Felix B Salazar; Katelyn E McCabe; James D Marks; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2014-08-04       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.